As next-generation sequencing technology advances and the cost decreases, whole genome sequencing (WGS) has become the preferred platform for the identification of somatic copy number alteration (CNA) events in cancer genomes. To more effectively decipher these massive sequencing data, we developed a software program named SEG, shortened from the word "segment". SEG utilizes mapped read or fragment density for CNA discovery. To reduce CNA artifacts arisen from sequencing and mapping biases, SEG first normalizes the data by taking the log 2 -ratio of each tumor density against its matching normal density. SEG then uses dynamic programming to find change-points among a contiguous log 2 -ratio data series along a chromosome, dividing the chromosome into different segments. SEG finally identifies those segments having CNA. Our analyses with both simulated and real sequencing data indicate that SEG finds more small CNAs than other published software tools.
Introduction
Copy number alteration (CNA) is one of the most prominent changes found in cancer genomes [1] [2] [3] [4] [5] [6] [7] [8] [9] , some of which contribute to cancer development and progression, e.g., deletion of tumor suppressors such as PTEN and amplification of oncogenes such as MYC.Genome wide CNA discovery is achieved via array-based technology traditionally [5, 10, 11] and next-generation sequencing (NGS) strategies recently [1, [12] [13] [14] [15] .Because of the high resolution and decreasing cost, NGS becomes the increasingly preferred platform for CNA-discovery [16] [17] [18] . For example, the cost of whole genome sequencing (WGS) of a 30× coverage has already decreased to below $1000 per genome, which is actually cheaper than high density arrays considering its comprehensiveness (finding CNAs, structural rearrangements and sequence mutations) and high resolution (covering N90% of the genome).
For effective CNA-discovery, WGS of a ≥ 10× coverage is typically performed (WGS depth can be approximated by the Poisson distribution, and a ≥ 10× coverage yields a Poisson distribution that is increasingly more normal-appearing).Such sequencing generates substantially more data than even the highest density arrays currently available, such as the Affymetrix genome-wide human SNP array 6.0 that have approximately 2 million probes and have been used for CNA-finding in many projects of the cancer genome atlas (TCGA) [5, 19, 20] .Importantly, while WGS can cover every base of the genome and could potentially identify every CNA in a cancer genome, it also presents new data analysis challenges.For example, because of the vast heterogeneity of a mammalian genome [21, 22] , some genomic regions (e.g.,GC-rich) are sequenced better than others, creating artificial CNAs.Moreover, mammalian genomes are very repeats-rich (e.g.,a substantial portion of the genome consists of repetitive sequences with ≥90% identities) [21, 22] , resulting in at least 10% of sequence reads that are unable to be mapped onto the genome unambiguously and are essentially unusable.This also leads to CNA artifacts.
A number of software tools have been developed in recent years for CNA-discovery from WGS data [13, 15, [23] [24] [25] [26] [27] .However, substantial issues still exist.For example, a study has compared a total of 10 such tools with simulated and real cancer sequencing data, and has concluded that the software BICseq 15 outperforms the others 18 .
However, for detecting small CNAs of b1 kb, the sensitivity is 0.33 even with BICseq and ranges 0.0\ \0.35 for the other algorithms. Hence, these tools have not fully realized the great potential of WGS identifying CNA events 18 .To address the challenges, we have developed a software tool called SEG and evaluated its performance as described below.
Materials and methods
2.1.1. The algorithm of SEG SEG consists of three major steps: 1)data normalization; 2) change-point finding; and 3)CNA identification, as illustrated in Fig. 1 and detailed below.
Data Normalization
To identify CNAs, SEG analyzes mapped read, for singleendsequencing, or fragment, for paired-end sequencing, density calculated based on continuous and non-overlapping tiling windows along a chromosome.The window size varies with the sequencing coverage, e.g.,100 bp for 20-30× coverage based on a previous publication 13 . To reduce CNA artifacts arisen from sequencing and mapping biases, we first normalize the density data by log 2
, where d i is the mapped read or fragment density of the i th window of either the tumor genome or the matching normal genome, and d is the corresponding genomewide average density.
Change-Point Finding
We have used the same change-point concept defined previously by the popular software tool CBS 23 for change-point finding.Briefly, let x 1 , x 2 , …, x n be the log 2 -ratiosof a chromosome, as defined in the section above, which are also assumed to be random variables.An index sequence of A = (a 1 , a 2 , ⋯, a v ), where 1 ≤ v b n, would be called achange-point sequence if meeting the following requirements.A change-
x a i +2 , ⋯, x a i+1 into two neighboring the i th and (i + 1) th segments.Importantly, the variables x a i−1 +1 , x a i−1 +2 , ⋯, x a i of the i th segment have a common distribution function F i .Similarly, the variables x a i +1 , x a i +2 , ⋯, x a i+1 of the (i + 1) th segment also share a common distribution function F i+1 .
However, F i differs from F i+1 . Based on this definition, SEG finds change-points by: 1)minimizing variations of the log 2 -ratios within the same segment (such that these variables share a common distribution function); and 2)ensuring that the log 2 -ratio means between any two neighboring segments are significantly different (such that their variable distribution functions differ).To implement this algorithm, SEG adapts a bottom-up approach via dynamic programming for change-point identification, which differs from CBS where a top-down strategy is used 23 , as illustrated below.
Assign the Average Segment Size
First, SEG requires the user to input an estimated initial average segment size, w, which is the total number of log 2 -ratios within a segment and must be ≥2.Because w determines the upper-limit of the total change-points for which SEG can identify, it is important to have an appropriate value for w.We recommend setting w = s + 1, where s is the minimal number of continuous log 2 -ratios that needs to be considered collectively for CNA identification.
2.1.5. Shift change-points via minimizing the sum of squared error (SSE) using dynamic programming
The user-inputtedw divides the log2-ratiosx 1 , x 2 , x 3 …, x n of a chromosome into t ¼ intð n w Þ segments with a preassigned changepointsequence of A = a 1 , a 2 , …, a t−1 .To find the true values of A, we first define the SSE as: let x i be the mean of the i th segment containing
SEG scans through the chromosome via a one-segment-overlapping sliding window of a total k (2 ≤ k ≤ t), a user-defined value, consecutive segments at a time to identify the correct positions for the subset of change-point sequence of A u = (a u , a u+1 …, a u+k−1 ).To do this, SEGutilizes dynamic programing to shift each change-point rightward orleftward until the sum of SSE of the k segments, given by f ða u ; …; a uþk−1 Þ ¼ P k j¼1 SSEða uþ j−1 ; a uþ j Þ; is minimized, whereSSE(a u+j−1 , a u +j ) represents SSE of the segment flanked by change-pointsa u+j−1 and a u+j .SEG begins with a u = 1 and determines the first k − 1 changepoints; then repeats the process by resetting a u = k − 1 and so on until the entire chromosome is examined.Note that if w × k ≥ n or k = t, dynamic programming will be applied to the whole chromosome and the entire change-point set A = a 1 , a 2 , …, a t−1 will be determined at one time.
CNA Finding (Segment-Labeling)
The change-points identified through the procedure described above divide a chromosome into different segments.To determine which segments are significantly amplified or deleted, we use a false discovery rate (FDR) controlling procedure as follows.Let x i and l be the mean and total number of log 2 -ratios of a segment, SEG first calculates the p-value of each segment of the genome by using z-test given
, where μ and σare the genome-wide mean and standard deviation.Then, the Benjamini and Hochberg step-up method [28] is used for CNA identification by controlling the FDR at a certain desired value.We call this step as "segment-labeling" (Fig. 1 ), because amplified, deleted, and unchanged segments are respectively labeled with +1, −1, and 0 in the final output file.
In current implementation of SEG, two additional cutoffs can be used to make the selected segments biologically significant.First, to avoid segments with a very small x i but a very large l (which are unlikely to be CNA) being selected, a cutoff value m is used to select only those segments with their log 2 -ratio mean x i satisfying j x i j ≥m.Similarly, another Fig. 1 . The algorithm of SEG. SEG will: 1)normalize the data and exclude the log 2 -ratio outliers (smooth data); 2)identify change-points; and 3)find CNAs (label segments).For change-point detection, SEG first depends upon the user's input to assign initial changepoints, and then loops through the SSE (sum of squared error) to remove insignificant change-points using dynamic programming (see text).The program is implemented in C and can be downloaded from GitHub at https://github.com/ZhaoS-Lab/SEG. cutoff s is used to select those segments having a total log 2 -ratio number l meeting l ≥ s.
Log 2 -Ratio Data Smoothing
We followed the same data smoothing procedure described by Olshen etal. [23] to exclude the log 2 -ratio outliers.Briefly, let x 1 , x 2 , …, x n be the log 2 -ratios of a chromosome, and x i and x j (j ≠ i) be the maximum (or minimum) and the next maximum (or minimum) log 2 -ratios in the region of x i−R , …, x i, …, x i+R where R was a small integer (we set R = 2 as suggested 23 ), respectively.If |x i − x j | ≥ Lσ, we replaced x i by m + Mσ (if x i is the maximum) or m − Mσ(if x i is the minimum), where σ is the genome-wide log 2 -ratio standard deviation and m is the median of
M and L are constants, and we set L = 4, M= 2, as described 23 .This process modified ≤0.1% of the log 2 -ratios of a genome for those analyzed.
Simulated Data and Real Cancer Data Used to Evaluate the Performance of SEG
Both simulated and real data were used to evaluate SEG.For simulated data, we followed the same procedures as described 18 to generate 10 samples of human chromosome 22.Briefly, for each sample, a total of 5 heterozygous deletions, 5 homozygous deletions, and 10 amplifications with copy number randomly choosing between three and eight were introduced to human chromosome 22.The size of these CNA events were sampled from a uniform distribution ranged between 100 bp to 10 Mb as described 18 .
For the real genomic sequencing data, we chose to use three canine mammary cancer cases, of which both the tumor and matching genomes were sequenced to 12-17× coverage 4 .These cancers were also subjected to 385 K array comparative genome hybridization (aCGH)
analyses, which indicate that they represent CNA-extensive, −moderate, and -sparse genomes 4 .aCGH studies were conducted as previously described 4 using the 385 K canine CGH array chips from Roche NimbleGen Systems, Inc.The log 2 -ratio value of each probe was collected and normalized following manufacturer's instruction.
Other Software Tools
BICseq and FREEC were run as described by Alkodsi etal. [18] . CBS was run with default parameters via DNAcopy from bioconductor.org/ packages/release/bioc/html/DNAcopy.html, and CNAs were identified with the same log2-ratio cutoff as SEG.
Results

SEG Identifies more Small CNAs of b1 Kb than BICseq in Simulated Data
Alkodsi etal. 18 compared a total of 10 published software tools, and concluded that BICseq 15 is the best-performed among them in both sensitivity and specificity for detecting somatic CNAs from cancer genome sequencing data.We hence focused on comparing SEG to BICseq to evaluate the performance of SEG, using simulated data of ten test samples of chromosome 22 harboring twenty CNAs generated as described by Alkodsi etal. 18 (see Materials and Methods).To run SEG, we first divided the chromosome into tiling windows of 100 bp, because of the 30× sequence coverage, and calculated the average mapped fragment density for each window.Then, we computed the log 2 -ratio of the density of a test chromosome 22 (with CNAs) against the reference chromosome 22 (without CNAs) for each window.Windows with no reads mapped to them and hence with zero density in either the test or reference chromosome are excluded from further analysis.Among these windows, those with zero density in the test chromosome and with density in the reference chromosome reaching the top 2.5% of its density distribution are considered as homozygous deletions, the reverse of which are considered as high level amplifications (in real cancer data, these windows should be rarer due to reasons such as contaminating non-tumor or tumor cells in the tumor or normal sample respectively). For change-point identification, we tested SEG by setting w (the initial segment size, i.e.,the number of log 2 -ratio) and k (the number of segments for dynamic programming) to various values, and found the results are largely consistent.The analysis described below was performed by setting w = 5 and k = 1001.For CNA-finding, we set FDR ≤ 0.05, s = 1 and m = σ, where s and m represent the minimum cutoffs of the log 2 -ratio number and mean respectively of a segment with CNA, while σ is the genome-wide standard deviation of log 2 -ratios. These parameters and cutoffs are mostly the default setting ofSEG.
Each of the 10 simulated human chromosome 22 samples harbors 10 deletions and 10 amplifications with size ranged from 100 bp to10 Mb, with 2 amplifications and 2 deletions falling in each bin of 100bp-1 kb, 1 kb-10 kb, 10 kb-100 kb, 100 kb-1 Mb, and 1 Mb-10Mb. Overall, SEG detects these CNA events with approximately the same sensitivities, ranging from 0.90 to 0.97, and specificities, ranging from 0.95 to 0.98, as BICseq in these samples ( Fig. 2A and B) .However, for detecting small CNAs of 100 bp-1 kb, our analyses indicate that SEG significantly outperformed BICseq, with the sensitivity ranging from 0.72 to 1.00 with an average of 0.91, compared to a 0.28-0.44 range and a 0.34 average for BICseq 18 (Fig. 2C) .
For large CNAs of N1 Mb, BICseq performed better than SEG, with an average sensitivity of 1.00 for BICseq versus 0.91 for SEG (Fig. 2C) .This is especially so for detecting 1-copy gain event of N1 Mb (Fig. 2D) , with an average sensitivity of 0.90 for BICseq and 0.74 for SEG.
To further evaluate SEG, we compared SEG to two additional software tools that use different segmentation strategies. One is FREEC [26] , a well-cited tool for copy number and allele content determination and ranked the 2nd best performed (after BICseq) by Alkodsi etal. [18] . The other is CBS [23] , the most cited CNA tool as of today to our knowledge and used by TCGA [5, 19, 20] and numerous others (although originally designed for the microarray platform, CBS can be applied on WGS data, e.g.,it has been used to segment the WGS data of TCGA). Moreover, as described previously, SEG utilizes the same change-point concept as CBS. Our comparison reached the same conclusion as described above-SEG is more sensitive in discovering small CNAs than either FREEC or CBS (Fig. 2C) . Consistent with the evaluation by Alkodsi etal. [18] , our analysis also indicates that the sensitivity of FREEC is very high for large (N10Kb) CNA discovery but very low for small CNA detection (Fig. 2) . CBS is underperformed than SEG in nearly every aspect examined (Fig. 2) .
SEG Identifies both Large and Small CNAs from Real Cancer WGSData
We applied SEG on three canine mammary cancer cases (IDed 32,510, 76 and 406,434), each with its tumor and matching normal genomes undergone paired-endWGS of 12-17× sequence coverage and 20-32× fragment coverage 4 .In addition, aCGH analyses find very different CNA landscapes among the three cancer genomes, with tumor 32,510 having hardly any CNAs detected, tumor 76 harboring two large amplicons of N4 Mb, and tumor 406,434 having more extensive CNAs and with whole chromosome gain 4 .Hence, the three tumors provide a nice dataset to test the performance of SEG. We first divided each of the 39 canine chromosomes into 100 bp window, because of N20× fragment coverage, and calculated the fragment density in each window (Fig. 3A) .We then normalized each density against its genome-wide average to correct for the difference in sequencing/fragment coverage among the genomes (Fig. 3B) .Afterwards, we further normalized each corrected tumor density against its counterpart from the matching normal genome (Fig. 3C) , as described in Materials and Methods.As shown in Fig. 3 , the distribution of final tumor against normal density log 2 -ratios is significantly more normallooking than the original density distribution for each tumor, indicating that this approach is valid.
We then ran SEG on these normalized data for the three tumors and examined the identified CNA events to evaluate the SEG performance. First, SEG identified many CNAs from WGS among those found by aCGH.These include the two large amplicons of N4 Mb on chromosomes 12 and 16 of tumor 76, as well as the whole chromosome amplification of chromosome 13 and numerous deletions in tumor 406,434 (Fig. 4) .
SEG also identified many additional small CNAs (Table 1) .In tumor 32,510 (of which aCCH found very few CNAs), these CNAs are allbelow 3 kb, averaged 418 bp and 443 bp and totaling to 9 Mb and 13 Mb for amplifications and deletions respectively (Table1).These small CNAs are significantly increased in tumors 76 and 406,434 (Table1), which also harbor large CNAs averaged N10 kb in size (Table 2) .
To better understand these small CNAs identified by SEG, we performed several analyses. First, to evaluate whether they are false results created by SEG, we examined the distributions of their mapped fragment densities. We found that significantly more/fewer fragments were mapped to those amplified/deleted regions in the tumor samples than in the normal samples (Fig.S1) . Hence, these small CNAs are indeed amplification/deletion events, not false results created by SEG. Second, to evaluate whether these small CNAs are sequencing/mapping artifacts (i.e.,better or worse sequenced/mapped than an average genomic region) or play a role in cancer, we examined their GC, repetitive sequence and gene contents. For GC and repeat contents, we found no clear and consistent differences between small and big CNAs (Tables1 and 2). Our analysis revealed, however, that these small CNAs harbor more genes, compared to large CNAs or an average genomic region. Specifically, the average exon density is one per 5-10 kb for small CNAs, compared to one per 8-18 kb for big CNAs and one per 12 kb genome-wide (Tables1 and 2). Furthermore, the genes harbored by small CNAs are more enriched in cell cycle and other cancer-related functions, compared to those of large CNAs. These analyses indicate that thesesmall CNAs may have a role in cancer development and progression.
SEG Performance
Because of dynamic programming, SEG runs fast.Using a PC with 2GB RAM,SEG takes a few minutes to process a sample of canine 384 K aCGH [7] or human 2 M SNP array 19 studies.WGS has significantly more log 2 -ratios, and the speed depends on the user input for k, the number of segments on which dynamic programming is applied at a time.If setting k = 101, this will take less than half an hour to finish a 30×WGS genome using a PC with 2GB RAM.We have compared the results of having small k (101) and large k (covering the entire chromosome), the results agree N90%.SEG can be obtained from the GitHub at https://github.com/ZhaoS-Lab/SEG.
Discussion
Unlike microarrays that are restricted by the probes, deep WGS can cover every single base of the genome and has the potential to identify somatic CNAs of all size in a cancer genome.However, current published software tools examined have a low sensitivity (b0.35) detecting small CNAs of b1kb 18 , unable to realize the full potential of deep WGS in finding smaller CNAs.To address this issue, we have developed a software tool, SEG.Based on simulated data, SEG is able to detect CNAs of b1 kb with N0.9 sensitivities, outperforming other software tools compared 18 .
The core algorithm of SEG is change-point detection among the data series along a chromosome.We have used the same change-point definition as the popular software CBS 23 .However, unlike CBS 23 which uses a top-down approach for change-point detection, SEG uses a bottom-up approach, with the upper limit of the total changepointsdetermined by the user and utilizing dynamic programming for change-point discovery.These differences allow SEG to more accurately determine small CNAs. SEG identifies substantial amount of small CNAs of b3 kb in WGS data of the three cancer genomes which are not found by aCGH.Our analysis indicates that these small CNAs are not false events created by SEG. Instead, these small CNAs could be cancer drivers (because of their higher gene content and enrichment in cancer-related functions) or passengers (e.g.,arising from increased cancer genomic instability and defective DNA repair), or simply artifacts due to sequencing or mapping biases (e.g.,GC-rich regions or repetitive sequences such as Alu, LINEs, etc.).
Sequencing/mapping originated artifact CNAs vary with the sequencing depth, as well as the window size chosen to calculate the log2-ratios (see Materials and Methods). Except for a publication that suggests using 100 bp windows for 20-30× sequence coverage for germline copy number variation discovery 13 , we have not yet found a study that discusses the appropriate window size for cancer CNA finding. We will try to develop a statistical model that determines the window size based on sequencing depth to minimize artifact CNAs. Second, even though SEG normalizes the tumor data against the matching normal data to reduce artificial CNAs arising from sequencing and mapping biases, substantial issues remain, especially for low coverage WGS.Data normalization remains a significant challenge and better normalization strategies need to be developed.Third, the results of SEG vary with several user-input values, including initial segment size as well as cutoffs on minimal log 2 -ratio number and mean. Choosing appropriate values will also reduce artifact CNAs.
To narrow down small CNAs that are more likely cancer-associated, we first plan to add a new function to SEG to identify small CNAs that are clustered in the genome.These CNA clusters should be more cancer-relevant, compared to random small CNAs.Second, we will modify SEG to give users the option to exclude copy number variations identified among normal individuals.Third, many genomic sites are already known to be recurrently amplified/deleted in human cancers (e.g., from TCGA studies [5, 19, 20] ). Small CNAs that locate within those genomic regions have a higher probability to be cancer-associated event. Moreover, small CNAs that harbor known cancer genes or genes with cancer-related functions (e.g.,cell proliferation, apoptosis, invasion, etc.) are more likely to be cancer drivers. Finally, we note again that small CNAs identified by SEG contain more genes, especially those with cancer-related functions. More studies are required to understand the significance of these small CNAs in cancer development and progression.
For detection of N1 Mb large gains and losses, SEG has a lower sensitivity compared to BICseq 18 and FREEC [26] .Hence, SEG needs further improvement in this aspect.For current CNA discovery, we recommend using SEG for more sensitive detection of small CNAs, and in combination with another program (e.g.,BICseq, FREEC, etc.) for large CNA discovery. Finally, we emphasize once again that SEG requires several user inputs, the values of which will influence the outcome of SEG. Hence, for new datasets, users may need to try different input values and choose the most appropriate ones. Supplementary data to this article can be found online at https://doi. org/10.1016/j.csbj.2018.09.001.
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